Alvotech (ALVOW) Competitors $1.32 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrendsBuy This Stock ALVOW vs. ATNFW, LBPSW, AEHAW, AIMDW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate 180 Life Sciences (NASDAQ:ATNFW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations. Is ATNFW or ALVOW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Alvotech N/A N/A N/A Does the MarketBeat Community believe in ATNFW or ALVOW? 180 Life Sciences and Alvotech both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AAlvotechN/AN/A Which has preferable valuation and earnings, ATNFW or ALVOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AAlvotech$489.68MN/AN/AN/AN/A Does the media refer more to ATNFW or ALVOW? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. Alvotech's average media sentiment score of 0.98 beat 180 Life Sciences' score of 0.59 indicating that Alvotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 180 Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alvotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAlvotech beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVOW vs. The Competition Export to ExcelMetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.19B$5.54B$7.98BDividend YieldN/A2.92%5.37%4.21%P/E RatioN/A3.9322.5618.87Price / SalesN/A496.31402.24106.74Price / CashN/A10.2538.1834.62Price / BookN/A5.496.764.32Net IncomeN/A$20.70B$3.22B$247.98M7 Day Performance3.13%1.05%3.04%2.81%1 Month Performance18.92%6.08%11.86%13.35%1 Year Performance-59.63%97.40%16.40%4.35% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOWAlvotechN/A$1.32flatN/AN/A$0.00$489.68M0.004Gap DownATNFW180 Life SciencesN/A$0.01-1.3%N/A-14.1%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002AIMDWAinosN/A$0.10-5.9%N/AN/A$0.00$20,729.000.0040Positive NewsACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02-20.5%N/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.04-12.6%N/A-33.3%$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.02-5.1%N/A-81.4%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12+12.1%N/A-86.4%$0.00N/A0.008CELUWCelularityN/A$0.04-10.1%N/AN/A$0.00$48.20M0.00220Positive NewsCINGWCingulateN/A$0.04+10.5%N/A+78.9%$0.00N/A0.0020Positive NewsGap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALVOW) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALVOW Stock Free ALVOW Stock Alerts